MiNK Therapeutics, Inc.
INKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,785 | -$22,458 | -$27,991 | -$30,213 |
| Dep. & Amort. | $215 | $205 | $122 | $78 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,810 | $3,860 | $3,027 | $1,745 |
| Change in WC | $460 | $2,897 | $8,767 | $3,736 |
| Other Non-Cash | -$1,256 | -$267 | -$2,791 | $11,827 |
| Operating Cash Flow | -$9,555 | -$15,763 | -$18,867 | -$12,827 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$74 | -$250 | -$249 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$74 | -$250 | -$249 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $5,000 | $0 | $0 | $9,459 |
| Stock Issued | $5,800 | $0 | $0 | $39,797 |
| Stock Repurch. | $0 | -$478 | -$157 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $20 | $70 | $2 | $0 |
| Financing Cash Flow | $10,820 | -$407 | -$156 | $49,257 |
| Forex Effect | -$55 | -$25 | $19 | $17 |
| Net Chg. in Cash | $1,210 | -$16,268 | -$19,253 | $36,198 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,367 | $19,636 | $38,889 | $2,691 |
| End Cash | $4,577 | $3,367 | $19,636 | $38,889 |
| Free Cash Flow | -$9,555 | -$15,836 | -$19,117 | -$13,076 |